Fresenius Kabi USA LLC

FDA inspection history across 2 sites, 2013 to 2026

6
Form 483s
1
Warning letter

Every document, by year

  • Warning letter
  • Form 483

2013: one Form 483; 2015: one Form 483; 2020: one Form 483; 2022: one Form 483; 2023: one Form 483; 2026: one warning letter and one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2013–15Two Form 483s, at Melrose Park, Illinois.
  2. 2020–23Three Form 483s, at Melrose Park, Illinois.
  3. 2022The longest 483 on file: 6 observations over 15 pages at Melrose Park, Illinois.
  4. 2026One warning letter and one Form 483, at Melrose Park.

Cited most

Across all Fresenius Kabi USA observations on file

The complete Fresenius Kabi USA file.

All 7 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$589$693

15% off buying them one by one

Sites

Also: one document not tied to a site.

Documents

7 on file, newest first
DateDocumentPrice
2026-09-22Warning letter Warning letter$99
2026-02-06483 Form 483$99
2023-08-24483 Form 483$99
2022-06-30483 Form 483$99
2020-05-18483 Form 483$99
2015-09-01483 Form 483$99
2013-12-11483 Form 483$99

FEI number 1450022 · most recent document Sep 22, 2026

About Fresenius Kabi USA LLC

How many FDA Form 483s has Fresenius Kabi USA LLC received?

FDA Intel has 6 Form 483s on file for Fresenius Kabi USA LLC; the most recent is dated Feb 6, 2026.

When was Fresenius Kabi USA LLC last inspected by FDA?

The most recent FDA inspection document on file for Fresenius Kabi USA LLC is a Form 483 dated Feb 6, 2026, for the site in Melrose Park.

What did FDA cite at Fresenius Kabi USA LLC?

The regulations cited most in the observations on file for Fresenius Kabi USA LLC are 21 CFR 211.113 (Control of microbiological contamination), 4 times; 21 CFR 211.192 (Production record review), 3 times; 21 CFR 211.22(d) (Responsibilities of quality control unit), 3 times.

Has Fresenius Kabi USA LLC received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Fresenius Kabi USA LLC; the most recent is dated Sep 22, 2026.